1. Home
  2. FSUN vs MPLT Comparison

FSUN vs MPLT Comparison

Compare FSUN & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$35.52

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$29.99

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSUN
MPLT
Founded
1892
2018
Country
United States
United States
Employees
1186
133
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FSUN
MPLT
Price
$35.52
$29.99
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$45.00
$32.67
AVG Volume (30 Days)
141.0K
225.4K
Earning Date
04-27-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$79.34
N/A
Revenue Next Year
$14.67
N/A
P/E Ratio
$11.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.95
$12.24
52 Week High
$42.34
$33.28

Technical Indicators

Market Signals
Indicator
FSUN
MPLT
Relative Strength Index (RSI) 44.25 54.74
Support Level $34.44 $26.20
Resistance Level $37.12 $32.23
Average True Range (ATR) 0.87 2.16
MACD 0.03 -0.13
Stochastic Oscillator 38.49 71.94

Price Performance

Historical Comparison
FSUN
MPLT

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments; Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: